| 1st Jun 2018 3:00 pm |
RNS |
Block listing Interim Review |
| 1st Jun 2018 3:00 pm |
RNS |
Total Voting Rights |
| 1st Jun 2018 11:00 am |
RNS |
Director Declaration |
| 30th May 2018 7:00 am |
RNS |
Update on TERRANOVA PIII trial for Fasenra in COPD |
| 25th May 2018 7:00 am |
RNS |
AZ's Imfinzi: significant OS in Stage III nsclc |
| 21st May 2018 7:00 am |
RNS |
AZ regulatory submission in Japan for Forxiga |
| 21st May 2018 7:00 am |
RNS |
US FDA approves Lokelma for adult hyperkalaemia |
| 18th May 2018 5:30 pm |
RNS |
Result of AGM |
| 18th May 2018 7:00 am |
RNS |
AZN: Q1 2018 Results |
| 11th May 2018 7:00 am |
RNS |
AstraZeneca update on Fasenra PIII trial in COPD |
| 8th May 2018 11:00 am |
RNS |
EMA approves Lynparza: maintenance ovarian cancer |
| 8th May 2018 7:00 am |
RNS |
AZ and Luye Pharma enter agreement for Seroquel |
| 4th May 2018 12:00 pm |
RNS |
Director Declaration |
| 1st May 2018 3:00 pm |
RNS |
Total Voting Rights |
| 27th Apr 2018 12:30 pm |
RNS |
AZ: positive CHMP for Tagrisso first-line nsclc |
| 24th Apr 2018 7:00 am |
RNS |
AstraZeneca:high level results of the ARCTIC trial |
| 24th Apr 2018 7:00 am |
RNS |
Issue of Equity - AstraZeneca |
| 19th Apr 2018 7:00 am |
RNS |
FDA approves Tagrisso for 1st-line use in NSCLC |
| 13th Apr 2018 11:00 am |
RNS |
Notice of AGM |
| 5th Apr 2018 7:00 am |
RNS |
Directorate Change |
| 3rd Apr 2018 3:00 pm |
RNS |
Total Voting Rights |
| 3rd Apr 2018 7:00 am |
RNS |
FDA TO REVIEW MOXETUMOMAB FOR HAIRY CELL LEUKAEMIA |
| 3rd Apr 2018 7:00 am |
RNS |
AZ AND MSD SUBMIT LYNPARZA FOR BREAST CANCER IN EU |
| 28th Mar 2018 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 26th Mar 2018 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 22nd Mar 2018 4:48 pm |
RNS |
Lokelma approved in the EU |
| 12th Mar 2018 7:00 am |
RNS |
ASTRAZENECA UPDATES MYSTIC TRIAL TIMELINE |
| 7th Mar 2018 7:00 am |
RNS |
Filing of Form 20-F with SEC |
| 6th Mar 2018 11:00 am |
RNS |
Annual Financial Report |
| 1st Mar 2018 3:00 pm |
RNS |
Total Voting Rights |
| 23rd Feb 2018 12:35 pm |
RNS |
Lynparza CHMP for ovarian cancer maintainance |
| 19th Feb 2018 7:00 am |
RNS |
AstraZeneca's IMFINZI approved for Stage III nsclc |
| 15th Feb 2018 7:00 am |
RNS |
Selumetinib in NF1 gets FDA orphan drug status |
| 5th Feb 2018 2:00 pm |
RNS |
Director/PDMR Shareholding |
| 2nd Feb 2018 7:00 am |
RNS |
AZN: Full-Year 2017 Results |
| 1st Feb 2018 3:00 pm |
RNS |
Total Voting Rights |
| 26th Jan 2018 6:20 pm |
RNS |
AZ Reports Phase III Results for PT010 in COPD |
| 26th Jan 2018 7:00 am |
RNS |
AZ Reports Phase III Results for PT010 in COPD |
| 19th Jan 2018 7:00 am |
RNS |
ASTRAZENECA'S FASENRA RECEIVES APPROVAL IN JAPAN |
| 19th Jan 2018 7:00 am |
RNS |
LYNPARZA APPROVED IN JAPAN FOR OVARIAN CANCER |
